ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2212

Feasibility and Performance of HR-pQCT-Derived Joint Space Width Measurement As Outcome Parameter in Arthropathic Disease – Lessons from Hemochromatosis Arthropathy

Ursula Heilmeier1, Andrew J Burghardt1, Puneet Kapoor2, Georg Schett3, Reinhard Voll4 and Stephanie Finzel5, 1Department of Radiology & Biomedical Imaging, Musculoskeletal Quantitative Imaging Research, University of California, San Francisco, San Francisco, CA, 2University of California, San Francisco, San Francisco, CA, 3Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Department of Internal Medicine 3 – Rheumatology and Immunology, University Hospital Erlangen, Erlangen, Germany, 4Clinic for Rheumatology and Clinical Immunology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany, 5Department of Rheumatology and Clinical Immunology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: arthritis and hemochromatosis, HR-pQCT, Imaging

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Imaging of Rheumatic Diseases Poster III: Other Modalities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

High resolution peripheral quantitative computed tomography (HR-pQCT) allows in vivo 3 D imaging of human joint microstructure and joint space width (JSW) at an isotropic resolution of 82μm voxel size. As JSW is regarded a surrogate measure of arthritic disease activity, the HR-pQCT-derived JSW may qualify as an important rheumatologic outcome measure. To date, JSW was reproducibly computed with an ICC of 0.989 in healthy subjects with maintained metacarpophalangeal (MCP) joints. However, data are still lacking on the performance of HR-pQCT-derived JSW measurements in arthropathies with very narrow joint spaces. One of those arthropathies is hemochromatosis arthropathy (HA) which is characterized by excess iron-induced joint destruction and hook-like osteophyte formation. Objective: We aimed to determine in patients with HA the 1) feasibility of the HR-pQCT-derived JSW algorithm 2) performance of the JSW-algorithm in this narrow-spaced cohort by assessing failure rates in relation to the corresponding joint space widths 3) JSW cut-off value, below which the JSW algorithm is set to fail and would further require manual re-segmentation.

Methods: MCP of 29 HA patients were imaged on one HR-pQCT system (XtremeCT, Scanco Medical AG). From the images, the mean joint space width (JSW) was semi-automatically computed via an in-house developed and well-validated software as the mean of local 3D widths across the joint space. In case the software failed at the first JSW analysis attempt, each MCP was semi-manually segmented by a trained operator to separate the metacarpal head and phalangeal base and a second JSW-analysis was attempted.

Results: 76.2 % of all 84 MCP joint spaces were successfully segmented at the first attempt. 22.6% required semi-manual intervention while in one case the JSW remained undeterminable even after semi-manual correction due to direct contact between the metacarpal and phalangeal bones. MCPs were next subdivided by JSW tertile and failure rates recorded. In MCPs of the lowest tertile software failure rates were highest with 50 % failure in MCP2 joints, 44.4 % in MCP3 joints, and 22.2% failure rates in MCP4 joints. MCPs ranging in the medium JSW tertile showed 22% (MCP2), 33% (MCP3) and 22% (MCP4) failures rates. Joints with a JSW in highest tertile were all successfully segmentable at the first attempt (0% failure rate). When looking at a JSW-cut-off value, below which the JSW software would fail its segmentation, we observed that in general a mean JSW of <1.4 mm was associated with a high rate of software failure. In MCP 3 and 4 a cut-off of a mean JSW of ≥ 1.41 mm resulted in 100% successfully segmented cases.

Conclusion: Our findings suggest that HR-pQCT-derived JSW quantification in MCP joints is feasible even in arthropathies with known narrow joint spaces such as hemochromatosis arthropathy. Moreover, performance analysis indicated that the software performance seems to be best in the joints belonging to the highest JSW tertile, while joints with a mean JSW of 1.4 mm or smaller seem to fail very likely at the first analysis attempt and do require semi-manual corrections. Further work is needed to assess failure rates in other patient cohorts.


Disclosure: U. Heilmeier, None; A. J. Burghardt, None; P. Kapoor, None; G. Schett, None; R. Voll, None; S. Finzel, None.

To cite this abstract in AMA style:

Heilmeier U, Burghardt AJ, Kapoor P, Schett G, Voll R, Finzel S. Feasibility and Performance of HR-pQCT-Derived Joint Space Width Measurement As Outcome Parameter in Arthropathic Disease – Lessons from Hemochromatosis Arthropathy [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/feasibility-and-performance-of-hr-pqct-derived-joint-space-width-measurement-as-outcome-parameter-in-arthropathic-disease-lessons-from-hemochromatosis-arthropathy/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/feasibility-and-performance-of-hr-pqct-derived-joint-space-width-measurement-as-outcome-parameter-in-arthropathic-disease-lessons-from-hemochromatosis-arthropathy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology